Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
about
Cobalamin deficiency, hyperhomocysteinemia, and dementiaFolic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular StudyCerebral small vessel disease: Capillary pathways to stroke and cognitive declineThe role of hydrogen sulfide in strokeWhite Matter Lesion Progression: Genome-Wide Search for Genetic InfluencesBlood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityEffect of genetic variants associated with plasma homocysteine levels on stroke riskCerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlatesEndothelial cells and human cerebral small vessel disease.Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older personsCirculating biologic markers of endothelial dysfunction in cerebral small vessel disease: A reviewClinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportMood after stroke: a case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors.Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleedsRole of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitusMigraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study.White matter lesions and vascular cognitive impairment: part 1: typical and unusual causes.Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.Role of vitamin B(12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population.Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide researchHomocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease.Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patientsThe annexin A2 system and vascular homeostasisDiscovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions.Kidney disease as a determinant of cognitive decline and dementia.Age-related white matter changesGenetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.Blood biomarkers of ischemic stroke.Prevention and Management of Cerebral Small Vessel DiseaseNitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemiaEvaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography.Risk factor profile of cerebral small vessel disease and its subtypes.Reduced heart rate recovery is associated with poorer cognitive function in older adults with cardiovascular disease.Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study.Preservation of retinal structure and function after cilioretinal artery occlusion: a case reportAssociation of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype.
P2860
Q24609123-ADDC9EB0-2E12-4632-8281-E1666A1CF342Q24647967-7C6E61DA-C4B0-4B3E-A5A0-3AB9D9C61E19Q26776375-7DDC9D46-7FC3-492A-BE6B-F9D56732C656Q28073483-49E30300-96F1-4451-BB67-BE4ED2FF2017Q28601040-73679D0D-8409-4A48-9B7D-4C79FF5602E5Q28604099-273BAC09-7FC4-4582-B4BA-AABC19E42488Q30384553-972F62FE-0D1E-41BF-A580-96C74437CA53Q30450267-C461BAB9-DD06-486C-8D24-7ED82F0CB137Q30880425-8C69B241-AAB0-45B2-9214-6997F2611632Q30964050-C342C6CB-8E70-4BF0-AB33-E041EBFD8EBDQ30968601-06659E13-DD8B-4375-9EA5-70A78F1AF61BQ30980887-57C66E27-C355-4E33-AEC5-535C770A3C2AQ33721681-2376E0C5-DE63-46DD-9456-FA5E2405DCACQ33782306-73D2F44E-6AFD-4D22-A387-D9CE858074D5Q33830165-B54F58DF-F566-4A58-827D-5936F741D8E2Q33851501-198B6140-A83A-4219-A690-EFB7B72BBBC1Q33854234-D381CD4F-434E-49B5-B61E-BD29F4610282Q34081988-FE230B1B-AFFD-415F-8490-60C2014A26B0Q34156950-CAD5C306-193A-4209-A2C2-136B05DCE121Q34203276-29D48DBB-6D4F-44C9-9225-BA36C88C04B5Q34316338-CBA92263-0C5F-4BA7-8510-3D4192F09A8DQ34495773-02959F96-DCA9-4200-ABF7-C5CE75BD0A38Q34502082-8CCB780B-5762-4089-835B-CF063B787D50Q34988767-CDECFD00-8067-43F6-B98E-66CA710DA396Q35025553-20B9D98F-9A06-4139-8150-6890F4756634Q35028300-F8F31867-E859-4F0B-9E78-D405BAC1AE26Q35154045-B55B669B-235F-4325-B63F-881BBF3DB789Q35172510-20842CDC-2D2C-4BD6-AAAA-93E30D49DB63Q35180274-67C39190-DB91-4A22-968A-03EAC31888DFQ35184834-CE5F378F-618E-44BD-A80E-7051553D7DCFQ35579629-6F0D0CC2-4B97-46C6-A362-4BFA04BED46DQ35648087-5F24E3D4-2F14-4A11-AB8C-75C6BE2EB7A2Q35698425-A4D53C55-5672-4D70-8498-2E68023862AAQ35939206-438D0D2F-9FF8-4BE9-BC2C-5C9833B7FB2EQ36104129-64C4A967-FAE0-4EB5-9301-54F8919E05D4Q36226961-D5565553-A463-477E-B11D-802D1C8A558BQ36228637-66A5387A-4172-456C-A2E3-513213689382Q36342152-08F956B1-0B50-4B50-A1D8-72957B6C3865Q36585236-315711D0-0597-41C8-8314-41B2A5EB7A7BQ36597633-4DC5628E-12FA-40AE-9826-A49A163AADEC
P2860
Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@en
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@nl
type
label
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@en
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@nl
prefLabel
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@en
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@nl
P2093
P356
P1433
P1476
Homocysteine is a risk factor ...... g via endothelial dysfunction.
@en
P2093
Ahamad Hassan
Beverley J Hunt
Hugh S Markus
John M Bamford
Rachel Bell
Reuben D'Souza
Steve Jeffery
P304
P356
10.1093/BRAIN/AWH023
P407
P577
2003-11-07T00:00:00Z